Literature DB >> 28972877

Long noncoding RNA in liver cancer stem cells.

Zhaobin Cai1,2, Keyang Xu3,2, Yan Li4, Yuanlin Lv3, Jianfeng Bao1, Liang Qiao5.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies and a major cause of cancer-related deaths. HCC often has an insidious onset, fast progression, and high tendency of metastasis and recurrence, hence it is a highly fatal malignant tumor. The origin of HCC is still a topic of debate but studies over the past decade have clearly identified liver cancer stem cells (LCSCs) being a cardinal source of liver cancer. LCSCs are a small subset of cells with the unlimited ability of self-renewal, differentiation, and uncontrollable growth. LCSCs are also resistant to conventional therapies and are thus believed to be responsible for treatment failure. Recent studies have indicated that long noncoding RNA (lncRNAs) may play important roles in the regulation of the biological functions of cancer stem cells (CSCs). The roles of lncRNAs on the biological properties of LCSCs are unknown. In this review, we briefly summarize the published studies on the functions and underlying mechanisms of commonly reported lncRNAs in the regulation of LCSCs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28972877

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  7 in total

1.  LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.

Authors:  Chao Han; Bin Xu; Lin Zhou; Long Li; Chao Lu; Guo-Peng Yu; Yu-Shan Liu
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

2.  LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells.

Authors:  Mingguang Zhou; Zhihuai Dong; Sunhong Hu; Mang Xiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-21       Impact factor: 2.503

3.  Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.

Authors:  Dong-Mei Wu; Zi-Hui Zheng; Ying-Bo Zhang; Shao-Hua Fan; Zi-Feng Zhang; Yong-Jian Wang; Yuan-Lin Zheng; Jun Lu
Journal:  J Exp Clin Cancer Res       Date:  2019-06-06

4.  Mitotic quiescence in hepatic cancer stem cells: An incognito mode.

Authors:  Kandasamy Ashokachakkaravarthy; Biju Pottakkat
Journal:  Oncol Rev       Date:  2020-02-18

5.  Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression.

Authors:  Linsheng Wu; Haoxia Li; Shengyou Chen; Xiaoqiang Wu; Xiaomin Chen; Fangping Wang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

6.  Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling.

Authors:  Wei Zheng; Guo-Liang Shen; Ke-Yang Xu; Qiao-Qiao Yin; Tian-Chen Hui; Zhe-Wen Zhou; Cheng-An Xu; Shou-Hao Wang; Wen-Hao Wu; Ling-Fei Shi; Hong-Ying Pan
Journal:  World J Gastrointest Oncol       Date:  2022-01-15

7.  LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway.

Authors:  Yarui Li; Junbi Hu; Dan Guo; Wenhui Ma; Xu Zhang; Zhiyong Zhang; Guifang Lu; Shuixiang He
Journal:  Cancer Gene Ther       Date:  2022-03-25       Impact factor: 5.854

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.